Meeting
2023 ASCO Annual Meeting
Prevalence of unexpected actionable germline pathogenic variants identified on broad-based multi-gene panel testing in a cohort of cancer patients.
Authors
Kara K. Landry
University of Vermont Larner College of Medicine, Burlington, VT
Kara K. Landry , Michael DeSarno , Lindsay Kipnis , Farid Barquet Ramos , Katelyn Breen , Kaleigh Patton , Audrey Morrissette , Ryan Buehler , Chinedu Ukaegbu , Mersedeh Rohanizadegan , Matthew B. Yurgelun , Sapna Syngal , Huma Q. Rana , Judy Ellen Garber
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10523)
DOI
10.1200/JCO.2023.41.16_suppl.10523
Abstract #
10523
Poster Bd #
156
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
One of these is not like the others: A descriptive study of the attenuated phenotype of PMS2.
First Author: Edward D. Esplin
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Pathogenic variants among Mexican patients with colorectal cancer referred for genetic cancer risk assessment.
First Author: Jose Luis Rodriguez Olivares
Poster
2017 Gastrointestinal Cancers Symposium
Oesophageal cancer: Commonly familial, possibly heritable.
First Author: Niamh Peters
Poster
2024 ASCO Breakthrough
Translating potential germline findings from tumour profiling into routine clinical care.
First Author: Milita Zaheed